NeoStem, Inc. (AMEX: NBS) is focused on the delivery of adult stem cell therapeutics to consumers concerned about their health. The Company is currently developing a nationwide network of adult stem cell collection centers that enable people to store their own unique stem cells for personal use later on if critical medical needs arise.
Currently hundreds of stem cell-based research programs and clinical trials are investigating the uses of these non-controversial adult stem cells. NeoStem has positioned itself as a leader in the national trend toward protecting one’s future health as the United States’ population continues to encounter serious health issues.
The Company’s business plan is a service model that is highly-scalable, consequently minimizing risks usually associated with most long-term biopharmaceutical research and development. Under its strategic business plan, NeoStem’s stem cell collection systems will be located in existing physician offices and medical facilities where professional care can be administered by trusted personal doctors and medical professionals.
Let us hear your thoughts: NeoStem, Inc. (AMEX: NBS)